Key Slides on HCC Risk in Hepatitis B Infection: Considerations for Treatment and Monitoring

W. Grace L. H. Wong 博士，来自 Clinical Care Options (CCO)的慢性 HBV 患者的 HCC 风险评估和跨学科管理

Grace LH Wong, 医学博士 Released: April 16, 2021

Clinical Care Options (CCO) expert commentary on incorporating family history into clinical decision-making when caring for patients with hepatitis B

Anna Christina L. dela Cruz, MD Released: April 15, 2021

Dr. Grace L. H. Wong on HCC risk assessment and interdisciplinary management of HCC in patients with chronic HBV, from Clinical Care Options (CCO)

Grace LH Wong, MD Released: April 15, 2021

Clinical Care Options (CCO) video of panel discussion on HCC risk assessment, screening, surveillance, and interdisciplinary management in patients with HBV

Robert S. Brown, Jr., MD, MPH Paul Y. Kwo, MD Norah Terrault, MD, MPH Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ Pharmacists: 1.25 contact hours (0.125 CEUs) Released: March 26, 2021 Expired: March 25, 2022

Introduction: HCC in the Setting of Hepatitis B

Assessing HCC Risk in Patients With HBV

HCC Screening and Surveillance in Patients With HBV

Management of HCC: Liver Specialists as Leaders of the Multidisciplinary Team